Company intelligence / Profile preview

VIPUN Medical

Ownership: Private
Development stage: Preclinical

Overview

VIPUN Medical has developed a novel "smart" enteral feeding tube system that enables real-time measurement of stomach motility. This technology supports clinicians in identifying enteral feeding intolerance and making evidence-based nutrition decisions for critically ill patients. The company has partnered with Baxter International to support clinical studies and global commercialization efforts. As of the latest updates, the system was undergoing clinical validation and regulatory approval processes.

Therapeutic areas: Gastroenterology
Modalities: DeviceNon-pharmacological therapy
Industry: Physiological Monitoring

Partnerships

Baxter International Inc. – exclusive global distribution agreement and support for clinical/regulatory activities.

Beyond the preview

Go deeper on VIPUN Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VIPUN Medical.

Explore the full profile